Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Lipka

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Epigenetics|October 26, 2020
AmpliconDesign - an interactive web server for the design of high-throughput targeted DNA methylation assaysMaximilian Schönung, Jana Hess, Pascal Bawidamann, et al.
Blood|January 26, 2006
Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7Stefan Fröhling, Daniel B Lipka, Sabine Kayser, et al.
Bioinformatics (Oxford, England)|December 21, 2020
Methrix: an R/Bioconductor package for systematic aggregation and analysis of bisulfite sequencing dataAnand Mayakonda, Maximilian Schönung, Joschka Hey, et al.
Blood Advances|May 7, 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AMLSagarajit Mohanty, Fiorella Charles Cano, Razif Gabdoulline, et al.
Molecular Cancer Therapeutics|May 17, 2008
LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cellsDaniel B Lipka, Linda S Hoffmann, Florian Heidel, et al.
British Journal of Haematology|February 3, 2009
Bis(1H-indol-2-yl)methanones are effective inhibitors of FLT3-ITD tyrosine kinase and partially overcome resistance to PKC412A in vitroFlorian Heidel, Daniel B Lipka, Fian K Mirea, et al.
Plos One|July 21, 2012
Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cellsDaniel B Lipka, Marie-Christine Wagner, Marek Dziadosz, et al.
International Journal of Cancer|May 28, 2019
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic targetElias Orouji, Aniello Federico, Lionel Larribère, et al.
Cell Communication and Signaling : CCS|August 12, 2025
Activation of integrin signaling up-regulates pro-inflammatory cytokines in JAK2-V617F positive hematopoietic cellsConny K Baldauf, Corinna Fahldieck, Alexa Angenstein, et al.
Annals of Hematology|September 2, 2011
3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cellsFlorian H Heidel, Thomas S Mack, Elena Razumovskaya, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Epigenetics|October 26, 2020
AmpliconDesign - an interactive web server for the design of high-throughput targeted DNA methylation assaysMaximilian Schönung, Jana Hess, Pascal Bawidamann, et al.
Blood|January 26, 2006
Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7Stefan Fröhling, Daniel B Lipka, Sabine Kayser, et al.
Bioinformatics (Oxford, England)|December 21, 2020
Methrix: an R/Bioconductor package for systematic aggregation and analysis of bisulfite sequencing dataAnand Mayakonda, Maximilian Schönung, Joschka Hey, et al.
Blood Advances|May 7, 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AMLSagarajit Mohanty, Fiorella Charles Cano, Razif Gabdoulline, et al.
Molecular Cancer Therapeutics|May 17, 2008
LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cellsDaniel B Lipka, Linda S Hoffmann, Florian Heidel, et al.
British Journal of Haematology|February 3, 2009
Bis(1H-indol-2-yl)methanones are effective inhibitors of FLT3-ITD tyrosine kinase and partially overcome resistance to PKC412A in vitroFlorian Heidel, Daniel B Lipka, Fian K Mirea, et al.
Plos One|July 21, 2012
Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cellsDaniel B Lipka, Marie-Christine Wagner, Marek Dziadosz, et al.
International Journal of Cancer|May 28, 2019
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic targetElias Orouji, Aniello Federico, Lionel Larribère, et al.
Cell Communication and Signaling : CCS|August 12, 2025
Activation of integrin signaling up-regulates pro-inflammatory cytokines in JAK2-V617F positive hematopoietic cellsConny K Baldauf, Corinna Fahldieck, Alexa Angenstein, et al.
Annals of Hematology|September 2, 2011
3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cellsFlorian H Heidel, Thomas S Mack, Elena Razumovskaya, et al.
Pageof 9